Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-18
1996-08-13
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514321, 546198, 546199, A61K 31445, C07D40514
Patent
active
055456430
ABSTRACT:
ee
Azaheterocyclylmethyl-chromans are prepared by reaction of corresponding methylchromans with corresponding azaheterocyclic compounds, optionally with subsequent variation of the substituents. The azaheterocyclyl-methyl-chromans can be used as active compounds in medicaments, in particular for the treatment of diseases of the central nervous system.
REFERENCES:
patent: 4153612 (1979-05-01), McCall
patent: 4470989 (1984-09-01), Henning
patent: 4826848 (1989-05-01), Janssens
Athen et al "Clinical Effects of Moderate and High Doses of Carpipramine" Index Medicus abs. No. 013711 (1977).
Traber et al. "5-HT1a receptor related anxiolytics" TIPS vol. 8, (1987) pp. 432-437.
De Vry Jean M. V.
Dompert Wolfgang
Glaser Thomas
Heine Hans-Georg
Schohe-Loop Rudolf
Bayer Aktiengesellschaft
Chang Ceila
LandOfFree
Azaheterocyclylmethyl-chromans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azaheterocyclylmethyl-chromans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaheterocyclylmethyl-chromans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048088